Literature DB >> 2395860

Interleukin 2 receptor beta chain expressed in an oligodendroglioma line binds interleukin 2 and delivers growth signal.

Y Okamoto1, S Minamoto, K Shimizu, H Mogami, T Taniguchi.   

Abstract

Interleukin 2 (IL-2) is a potent growth factor for T lymphocytes, playing a crucial role in the immune response. In view of the considerable evidence that the immunoregulatory cytokines (or lymphokines) also play a role in the growth and differentiation of cells in the central nervous system (CNS), we examined the operation of the IL-2 system in a cell line of CNS origin by expressing a cDNA encoding the beta chain of the human IL-2 receptor (IL-2R beta, a 75-kDa protein). When the cDNA was expressed in a human oligodendroglioma cell line, ONS-21, the IL-2R beta bound IL-2 with an affinity similar to that in lymphoid cells (Kd, approximately 2 nM). Furthermore, cell proliferation ([3H]thymidine incorporation) was stimulated by IL-2. These results demonstrate that the same cytokine receptor is functional in cells of the immune system and CNS and point to a molecular mechanism that is similar for growth-signal transduction between lymphoid and neural cells but that may be different in other cells, such as fibroblasts.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2395860      PMCID: PMC54581          DOI: 10.1073/pnas.87.17.6584

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Isolation and characterization of the human chromosomal gene for polypeptide chain elongation factor-1 alpha.

Authors:  T Uetsuki; A Naito; S Nagata; Y Kaziro
Journal:  J Biol Chem       Date:  1989-04-05       Impact factor: 5.157

Review 2.  The multi-subunit interleukin-2 receptor.

Authors:  T A Waldmann
Journal:  Annu Rev Biochem       Date:  1989       Impact factor: 23.643

3.  Immunoregulatory molecules and IL 2 receptors identified in multiple sclerosis brain.

Authors:  F M Hofman; R I von Hanwehr; C A Dinarello; S B Mizel; D Hinton; J E Merrill
Journal:  J Immunol       Date:  1986-05-01       Impact factor: 5.422

4.  A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells.

Authors:  T Uchiyama; S Broder; T A Waldmann
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

Review 5.  Lymphokines and the brain.

Authors:  A Fontana; P J Grob
Journal:  Springer Semin Immunopathol       Date:  1984

6.  A restricted cytoplasmic region of IL-2 receptor beta chain is essential for growth signal transduction but not for ligand binding and internalization.

Authors:  M Hatakeyama; H Mori; T Doi; T Taniguchi
Journal:  Cell       Date:  1989-12-01       Impact factor: 41.582

7.  Human interleukin 2 (IL 2) receptor beta chain allows transduction of IL 2-induced proliferation signal(s) in a murine cell line.

Authors:  T Doi; M Hatakeyama; S Minamoto; T Kono; H Mori; T Taniguchi
Journal:  Eur J Immunol       Date:  1989-12       Impact factor: 5.532

8.  Constitutive production of human interferons by mouse cells with bovine papillomavirus as a vector.

Authors:  R Fukunaga; Y Sokawa; S Nagata
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

9.  Multiple sclerosis. Oligodendrocyte survival and proliferation in an active established lesion.

Authors:  C S Raine; L Scheinberg; J M Waltz
Journal:  Lab Invest       Date:  1981-12       Impact factor: 5.662

Review 10.  The cytokine network.

Authors:  F R Balkwill; F Burke
Journal:  Immunol Today       Date:  1989-09
View more
  9 in total

1.  CD4 and CD8 regulate interleukin 2 responses of T cells.

Authors:  K Takahashi; M Nakata; T Tanaka; H Adachi; H Nakauchi; H Yagita; K Okumura
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

2.  Interferon-alpha and interleukin 2 synergistically enhance basic fibroblast growth factor synthesis and induce release, promoting endothelial cell growth.

Authors:  F Cozzolino; M Torcia; M Lucibello; L Morbidelli; M Ziche; J Platt; S Fabiani; J Brett; D Stern
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

3.  Functional coupling of the src-family protein tyrosine kinases p59fyn and p53/56lyn with the interleukin 2 receptor: implications for redundancy and pleiotropism in cytokine signal transduction.

Authors:  N Kobayashi; T Kono; M Hatakeyama; Y Minami; T Miyazaki; R M Perlmutter; T Taniguchi
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

4.  A role for the intermediate affinity IL-2R in the protection against glucocorticoid-induced apoptosis.

Authors:  A Rebollo; C Pitton; A García; J Gómez; A Silva
Journal:  Immunology       Date:  1995-03       Impact factor: 7.397

5.  Intermediate- and high-affinity interleukin-2 receptors expressed in an IL-4-dependent T-cell line induce different signals.

Authors:  A Rebollo; A Silva
Journal:  Immunology       Date:  1993-10       Impact factor: 7.397

6.  The integrity of the conserved 'WS motif' common to IL-2 and other cytokine receptors is essential for ligand binding and signal transduction.

Authors:  T Miyazaki; M Maruyama; G Yamada; M Hatakeyama; T Taniguchi
Journal:  EMBO J       Date:  1991-11       Impact factor: 11.598

7.  Association of p56lck with IL-2 receptor beta chain is critical for the IL-2-induced activation of p56lck.

Authors:  Y Minami; T Kono; K Yamada; N Kobayashi; A Kawahara; R M Perlmutter; T Taniguchi
Journal:  EMBO J       Date:  1993-02       Impact factor: 11.598

8.  Interleukin 2 activates extracellular signal-regulated protein kinase 2.

Authors:  G R Perkins; J Marvel; M K Collins
Journal:  J Exp Med       Date:  1993-10-01       Impact factor: 14.307

9.  Characterisation of a new mouse monoclonal antibody (ONS-M21) reactive with both medulloblastomas and gliomas.

Authors:  S Moriuchi; K Shimizu; Y Miyao; T Hayakawa
Journal:  Br J Cancer       Date:  1993-11       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.